Delivery Order SPE2DB22D1103-SPE2DB25FH2A2
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,237.52 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued under a competitively awarded contract with no set-aside designation, will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,594.24 to AmerisourceBergen Drug Corp on August 19, 2025, with completion anticipated by August 20, 2025. This firm fixed-price delivery order, issued under a competitive procurement with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,102.35 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order falls under a child contract arrangement and represents a routine pharmaceutical procurement from the prime contractor's existing indefinite delivery contract vehicle. The work will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $152,556.74 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, competitively awarded delivery order (Contract No. 4569202619) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,623.36 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $8,671.77 delivery order (Contract No. 4569354316) to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor will perform work at its corporate office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $112,938.83 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,004.72 delivery order to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The award was competitively made with no set-aside designation, and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $108,554.87 to AmerisourceBergen Drug Corp on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2A2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,024.55 to AmerisourceBergen Drug Corp on September 10, 2025, for URE-NA 15 gram powder packets (8 units). This firm fixed price delivery order, which is a child contract under a larger indefinite delivery vehicle, was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for the federal government, with extensive experience fulfilling medical procurement needs for military and veteran healthcare systems. This delivery order falls under the company's broader $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and authorizes the supply of a comprehensive range of pharmaceutical products, medical supplies, specialty medications, and vaccines to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability in meeting complex medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/10/25 |